| Frontiers in Public Health | |
| Biosecurity in Emerging Life Sciences Technologies, a Canadian Public Health Perspective | |
| Kirsten X. Jacobsen1  | |
| 关键词: biosafety; biosecurity; pathogen; toxin; laboratory; dual use; risk management; | |
| DOI : 10.3389/fpubh.2014.00198 | |
| 学科分类:卫生学 | |
| 来源: Frontiers | |
PDF
|
|
【 摘 要 】
Driven by innovation, science and technology are continually evolving. Over the past several years, the global scientific community and the world have had the opportunity to see firsthand the significant strides that have been made in the area of life science research, and the corresponding ethical, safety, and security questions that arise as a result of this work. The idea that well-intended research could be used for nefarious purposes is not new. The “dual-use” potential of advancing technologies has driven the dialog in a variety of sectors, including biological, chemical, and nuclear. In Canada, the Public Health Agency of Canada (PHAC) administers the Human Pathogens and Toxins Act (HPTA), the principle legislative tool overseeing the biosafety and biosecurity of activities involving human pathogens and toxins in Canada.
【 授权许可】
CC BY
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201904025685746ZK.pdf | 379KB |
PDF